Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States
The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND Although an infrequent occurrence, the placenta can adhere abnormally to the gravid uterus leading to significantly high maternal morbidity and mortality during cesarean section (CS). Contemporary national statistics related to a morbidly adherent placenta, referred to as placenta accreta spectrum (PAS), are needed. OBJECTIVE To examine national trends, characteristics, and perioperative outcomes of women who underwent CS for PAS in the United States. METHODS This is a population-based retrospective, observational study querying the National Inpatient Sample. The study cohort included women who underwent CS from 10/2015-12/2017 and had a diagnosis of PAS. The main outcome measures were patient characteristics and surgical outcomes related to PAS assessed by the generalized estimating equation on multivariable analysis. Temporal trend of PAS was also assessed by linear segmented regression with log transformation. RESULTS Of 2,727,477 cases that underwent CS during the study period, 8,030 (0.29%) had the diagnosis of PAS. Placenta accreta was the most common diagnosis (n=6,205, 0.23%), followed by percreta (n=1,060, 0.04%) and increta (n=765, 0.03%). The number of PAS cases increased by 2.1% every quarter-year from 0.27% to 0.32% (P=0.004). On multivariable analysis, (i) patient demographics: older age, tobacco use, recent diagnosis, higher comorbidity, and use of assisted reproductive technology, (ii) pregnancy characteristics: placenta previa, prior CS, breech presentation, and grand multiparity, and (iii) hospital factors: urban-teaching center and large bed capacity hospital, represented the independent characteristics related to PAS (all, P<0.05). The median gestational age at CS was 36 weeks for placenta accreta, and 34 weeks for both placenta increta and percreta versus 39 weeks for non-PAS cases (P<0.001). On multivariable analysis, CS complicated by PAS was associated with increased risk of: any surgical morbidities (78.3% versus 10.6%), CDC-defined severe maternal morbidity (60.3% versus 3.1%), hemorrhage (54.1% versus 3.9%), coagulopathy (5.3% versus 0.3%), shock (5.0% versus 0.1%), urinary tract injury (8.3% versus 0.2%), and death (0.25% versus 0.01%) compared to CS without PAS. When further analyzed by subtype, CS for placenta increta and percreta was associated with higher likelihood of hysterectomy (0.4% for non-PAS, 45.8% for accreta, 82.4% for increta, 78.3% for percreta, P<0.001) and urinary tract injury (0.2% for non-PAS, 5.2% for accreta, 11.8% for increta, 24.5% for percreta, P<0.001). Moreover, women in the placenta increta and percreta groups had markedly increased risks of surgical mortality compared to those without PAS (increta, odds ratio 19.9; and percreta, odds ratio 32.1). CONCLUSION Patient characteristics and outcomes differ across the PAS subtypes and women with placenta increta and percreta have considerably high surgical morbidity and mortality risks. One in 313 women undergoing CS had a diagnosis of PAS by the end of 2017 and the incidence appears to be higher than reported in previous studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Abnormal placentation: Twenty-year analysis
Wu, S., Kocherginsky, M., & Hibbard, J. U. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.12.074 · Cited by 1,331
FIGO classification for the clinical diagnosis of placenta accreta spectrum disorders,
Jauniaux, E., Ayres‐de‐Campos, D., Langhoff‐Roos, J., Fox, K. A., Collins, S., & Panel, F. P. A. D. A. M. E. C. (2019) · International Journal of Gynecology & Obstetrics · doi:10.1002/ijgo.12761 · Cited by 668
The management of placenta percreta: Conservative and operative strategies
O'Brien, J. M., Barton, J. R., & Donaldson, E. S. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70117-5 · Cited by 625
Eller, A. G., Bennett, M. A., Sharshiner, M., Masheter, C., Soisson, A. P., Dodson, M., & Silver, R. M. (2011) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182051db2 · Cited by 556
Silver, R. M., & Branch, D. W. (2018) · New England Journal of Medicine · doi:10.1056/nejmcp1709324 · Cited by 511
Placenta Praevia and Placenta Accreta: Diagnosis and Management: Green‐top Guideline No. 27a
Jauniaux, E., Alfirevic, Z., Bhide, A., Belfort, M., Burton, G., Collins, S., Dornan, S., Jurkovic, D., Kayem, G., Kingdom, J., et al. (2019) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15306 · Cited by 506
Belfort, M. A. (2010) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2010.09.013 · Cited by 484
Cahill, A. G., Beigi, R., Heine, R. P., Silver, R. M., & Wax, J. R. (2018) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2018.09.042 · Cited by 481
Shamshirsaz, A. A., Fox, K. A., Salmanian, B., Diaz-Arrastia, C. R., Lee, W., Baker, B. W., Ballas, J., Chen, Q., Van Veen, T. R., Javadian, P., et al. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2014.08.019 · Cited by 478
Morbidly Adherent Placenta Treatments and Outcomes
Bailit, J. L., Grobman, W. A., Rice, M. M., Reddy, U. M., Wapner, R. J., Varner, M. W., Leveno, K. J., Iams, J. D., Tita, A. T. N., Saade, G., et al. (2015) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000000680 · Cited by 313
Research works printed but not linked: 33
- Burton, 2015, What is the placenta?, Am J Obstet Gynecol, 213, 10.1016/j.ajog.2015.07.050 · DOI · Paper page
- Jauniaux, 2020, A new methodologic approach for clinico-pathologic correlations in invasive placenta previa accreta, Am J Obstet Gynecol, 222, 379.e1, 10.1016/j.ajog.2019.11.1246 · DOI · Paper page
- Matsuzaki, 2018, Conservative management of placenta percreta, Int J Gynaecol Obstet, 140, 299, 10.1002/ijgo.12411 · DOI
- Licon, 2020, Implementation of multidisciplinary practice change to improve outcomes for women with placenta accreta spectrum, Eur J Obstet Gynecol Reprod Biol, 246, 194, 10.1016/j.ejogrb.2020.01.010 · DOI
- 2018, Obstetric Care Consensus No. 7: placenta accreta spectrum, Obstet Gynecol, 132, e259, 10.1097/AOG.0000000000002983 · DOI · Paper page
- Read, 1980, Placenta accreta: changing clinical aspects and outcome, Obstet Gynecol, 56, 31
- Miller, 1997, Clinical risk factors for placenta previa-placenta accreta, Am J Obstet Gynecol, 177, 210, 10.1016/S0002-9378(97)70463-0 · DOI · Paper page
- Thurn, 2016, Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries, BJOG, 123, 1348, 10.1111/1471-0528.13547 · DOI · Paper page
- Thurn, 2019, Massive blood transfusion in relation to delivery: incidence, trends and risk factors: a population-based cohort study, BJOG, 126, 1577, 10.1111/1471-0528.15927 · DOI
- Marcellin, 2018, Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta, Am J Obstet Gynecol, 219, 193.e1, 10.1016/j.ajog.2018.04.049 · DOI · Paper page
- Charlson, 1987, A new method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chronic Dis, 40, 373, 10.1016/0021-9681(87)90171-8 · DOI · Paper page
- Mandelbaum, 2020, Conservative surgery for ovarian torsion in young women: perioperative complications and national trends, BJOG, 127, 957, 10.1111/1471-0528.16179 · DOI
- Matsuo, 2021, National trends and outcomes of morbidly obese women who underwent inpatient hysterectomy for benign gynecological disease in the USA, Acta Obstet Gynecol Scand, 100, 459, 10.1111/aogs.14034 · DOI
- Kim, 2000, Permutation tests for joinpoint regression with applications to cancer rates, Stat Med, 19, 335, 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z · DOI · Paper page
- Zeger, 1988, Models for longitudinal data: a generalized estimating equation approach, Biometrics, 44, 1049, 10.2307/2531734 · DOI · Paper page
- Greenland, 2016, Outcome modelling strategies in epidemiology: traditional methods and basic alternatives, Int J Epidemiol, 45, 565, 10.1093/ije/dyw040 · DOI · Paper page
- Pavlou, 2016, Review and evaluation of penalised regression methods for risk prediction in low-dimensional data with few events, Stat Med, 35, 1159, 10.1002/sim.6782 · DOI · Paper page
- Mandelbaum, 2020, The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States, Am J Obstet Gynecol, 223, 721.e1, 10.1016/j.ajog.2020.04.028 · doi:10.1016/j.ajog.2020.04.028
- von Elm, 2007, Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies, BMJ, 335, 806, 10.1136/bmj.39335.541782.AD · DOI · Paper page
- Baldwin, 2017, Maternal and neonatal outcomes following abnormally invasive placenta: a population-based record linkage study, Acta Obstet Gynecol Scand, 96, 1373, 10.1111/aogs.13201 · DOI · Paper page
- Martin, 2019, Births: final data for 2018, Natl Vital Stat Rep, 68, 1
- Einerson, 2020, Placenta accreta spectrum disorder: uterine dehiscence, not placental invasion, Obstet Gynecol, 135, 1104, 10.1097/AOG.0000000000003793 · DOI · Paper page
- Kyozuka, 2019, Risk factors for placenta accreta spectrum: findings from the Japan environment and children’s study, BMC Pregnancy Childbirth, 19, 447, 10.1186/s12884-019-2608-9 · DOI
- Iacovelli, 2020, Risk factors for abnormally invasive placenta: a systematic review and meta-analysis, J Matern Fetal Neonatal Med, 33, 471, 10.1080/14767058.2018.1493453 · DOI · Paper page
- Miller, 2021, Placenta accreta spectrum among women with twin gestations, Obstet Gynecol, 137, 132, 10.1097/AOG.0000000000004204 · DOI
- Clark, 2008, Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery, Am J Obstet Gynecol, 199, 36.e1, 10.1016/j.ajog.2008.03.007 · DOI · Paper page
- Kingdom, 2020, Minimizing surgical blood loss at cesarean hysterectomy for placenta previa with evidence of placenta increta or placenta percreta: the state of play in 2020, Am J Obstet Gynecol, 223, 322, 10.1016/j.ajog.2020.01.044 · DOI
- Carusi, 2020, Placenta accreta spectrum without placenta previa, Obstet Gynecol, 136, 458, 10.1097/AOG.0000000000003970 · DOI
- Buca, 2018, Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysis, Ultrasound Obstet Gynecol, 52, 304, 10.1002/uog.19070 · DOI · Paper page
- Jotwani, 2021, Positive predictive value of ICD-10 codes for placenta accreta syndrome: a single center validation study, Am J Obstet Gynecol, 224, S523, 10.1016/j.ajog.2020.12.865 · doi:10.1016/j.ajog.2020.12.865
- Couret, 2019, Patterns of care for women with placenta accreta spectrum, J Matern Fetal Neonatal Med
- Erfani, 2019, Maternal outcomes in unexpected placenta accreta spectrum disorders: single-center experience with a multidisciplinary team, Am J Obstet Gynecol, 221, 337.e1, 10.1016/j.ajog.2019.05.035 · DOI
- Silver, 2015, Center of excellence for placenta accreta, Am J Obstet Gynecol, 212, 561, 10.1016/j.ajog.2014.11.018 · DOI · Paper page
Cited by
Searching for placenta percreta: a prospective cohort and systematic review of case reports
Jauniaux, E., Hecht, J. L., Elbarmelgy, R. A., Elbarmelgy, R. M., Thabet, M. M., & Hussein, A. M. (2022) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2021.12.030 · Cited by 82
Diagnosis of placenta accreta spectrum using ultrasound texture feature fusion and machine learning
Young, D., Khan, N., Hobson, S. R., & Sussman, D. (2024) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2024.108757 · Cited by 15
Pregnancy Outcomes Associated With Use of Tobacco and Marijuana
Layoun, V., Ohnona, A., & Tolosa, J. E. (2022) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000699 · Cited by 10
Metadata
- Authors
- Matsuzaki, S., Mandelbaum, R. S., Sangara, R. N., McCarthy, L. E., Vestal, N. L., Klar, M., Matsushima, K., Amaya, R., Ouzounian, J. G., & Matsuo, K.
- Venue
- American Journal of Obstetrics and Gynecology
- Publisher
- Elsevier BV
- Published
- 2021-11
- Volume
- 225
- Issue
- 5
- Pages
- 534.e1-534.e38
- ISSN
- 0002-9378 (ISSN-L)
- OpenAlex
- W3155964117
- Cited by
- 213
- References
- 14
- FWCI
- 29.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. https://app.cochat.ai/papers/10.1016/j.ajog.2021.04.233
- The paper
- Matsuzaki, S., Mandelbaum, R. S., Sangara, R. N., McCarthy, L. E., Vestal, N. L., Klar, M., Matsushima, K., Amaya, R., Ouzounian, J. G., & Matsuo, K. (2021). Trends, characteristics, and outcomes of placenta accreta spectrum: a national study in the United States. American Journal of Obstetrics and Gynecology. https://doi.org/10.1016/j.ajog.2021.04.233
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.